These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22102833)

  • 1. When Does ALS Start? ADAR2-GluA2 Hypothesis for the Etiology of Sporadic ALS.
    Hideyama T; Kwak S
    Front Mol Neurosci; 2011; 4():33. PubMed ID: 22102833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
    Yamashita T; Kwak S
    Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons.
    Hideyama T; Yamashita T; Aizawa H; Tsuji S; Kakita A; Takahashi H; Kwak S
    Neurobiol Dis; 2012 Mar; 45(3):1121-8. PubMed ID: 22226999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced loss of ADAR2 engenders slow death of motor neurons from Q/R site-unedited GluR2.
    Hideyama T; Yamashita T; Suzuki T; Tsuji S; Higuchi M; Seeburg PH; Takahashi R; Misawa H; Kwak S
    J Neurosci; 2010 Sep; 30(36):11917-25. PubMed ID: 20826656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique nuclear vacuoles in the motor neurons of conditional ADAR2-knockout mice.
    Sasaki S; Takenari Yamashita ; Hideyama T; Kwak S
    Brain Res; 2014 Mar; 1550():36-46. PubMed ID: 24440630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell death cascade and molecular therapy in ADAR2-deficient motor neurons of ALS.
    Yamashita T; Kwak S
    Neurosci Res; 2019 Jul; 144():4-13. PubMed ID: 29944911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy in spinal motor neurons of conditional ADAR2-knockout mice: An implication for a role of calcium in increased autophagy flux in ALS.
    Sasaki S; Yamashita T; Kwak S
    Neurosci Lett; 2015 Jun; 598():79-84. PubMed ID: 25980994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Intracellular Milieu of ADAR2-Deficient Motor Neurons in Amyotrophic Lateral Sclerosis.
    Yamashita T; Akamatsu M; Kwak S
    Genes (Basel); 2017 Feb; 8(2):. PubMed ID: 28208729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative features of sporadic amyotrophic lateral sclerosis: Motor neurons of Onuf's nucleus survive in ADAR2-conditional knockout mice.
    Hideyama T; Teramoto S; Kato H; Terashi H; Kwak S; Aizawa H
    J Neurol Sci; 2024 Aug; 463():123142. PubMed ID: 39053342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological features of glial cells and motor neurons in the anterior horn of the spinal cord in sporadic ALS using ADAR2 conditional knockout mice.
    Naito M; Hideyama T; Teramoto S; Saito T; Kato H; Terashi H; Kwak S; Aizawa H
    J Neurol Sci; 2023 Jan; 444():120520. PubMed ID: 36527980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMPA receptor-mediated neuronal death in sporadic ALS.
    Kwak S; Hideyama T; Yamashita T; Aizawa H
    Neuropathology; 2010 Apr; 30(2):182-8. PubMed ID: 20102521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis.
    Kwak S; Kawahara Y
    J Mol Med (Berl); 2005 Feb; 83(2):110-20. PubMed ID: 15624111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rescue of amyotrophic lateral sclerosis phenotype in a mouse model by intravenous AAV9-ADAR2 delivery to motor neurons.
    Yamashita T; Chai HL; Teramoto S; Tsuji S; Shimazaki K; Muramatsu S; Kwak S
    EMBO Mol Med; 2013 Nov; 5(11):1710-9. PubMed ID: 24115583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular link between inefficient GluA2 RNA editing and TDP-43 pathology in ALS motor neurons].
    Kwak S
    Brain Nerve; 2012 May; 64(5):549-56. PubMed ID: 22570068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel etiological and therapeutic strategies for neurodiseases: RNA editing enzyme abnormality in sporadic amyotrophic lateral sclerosis.
    Hideyama T; Yamashita T; Nishimoto Y; Suzuki T; Kwak S
    J Pharmacol Sci; 2010; 113(1):9-13. PubMed ID: 20424386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficient RNA-editing enzyme ADAR2 in an amyotrophic lateral sclerosis patient with a FUS(P525L) mutation.
    Aizawa H; Hideyama T; Yamashita T; Kimura T; Suzuki N; Aoki M; Kwak S
    J Clin Neurosci; 2016 Oct; 32():128-9. PubMed ID: 27343041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA editing of the Q/R site of GluA2 in different cultured cell lines that constitutively express different levels of RNA editing enzyme ADAR2.
    Yamashita T; Tadami C; Nishimoto Y; Hideyama T; Kimura D; Suzuki T; Kwak S
    Neurosci Res; 2012 May; 73(1):42-8. PubMed ID: 22366356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-occurrence of TDP-43 mislocalization with reduced activity of an RNA editing enzyme, ADAR2, in aged mouse motor neurons.
    Hideyama T; Teramoto S; Hachiga K; Yamashita T; Kwak S
    PLoS One; 2012; 7(8):e43469. PubMed ID: 22916266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The AMPA receptor antagonist perampanel robustly rescues amyotrophic lateral sclerosis (ALS) pathology in sporadic ALS model mice.
    Akamatsu M; Yamashita T; Hirose N; Teramoto S; Kwak S
    Sci Rep; 2016 Jun; 6():28649. PubMed ID: 27350567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Perampanel for Sporadic Amyotrophic Lateral Sclerosis].
    Aizawa H; Kwak S
    Brain Nerve; 2019 Nov; 71(11):1270-1278. PubMed ID: 31722313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.